| Roopa Industries Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 530991 |
NSE Symbol : - |
P/E(TTM) : 19.79 |
|
ISIN Demat : INE443C01010 |
Div & Yield% : 0.00 |
EPS(TTM) : 2.45 |
|
Book Value(₹) : 23.19 |
Market Cap(₹Cr) : 38.14 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 28.74 | 35.07 | 29.83 | 30.73 | 25.61 | 34.51 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 28.74 | 35.07 | 29.83 | 30.73 | 25.61 | 34.51 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.00 | 0.02 | 1.14 | 0.92 | 0.00 | 0.24 |
| Total Income | 28.75 | 35.09 | 30.97 | 31.65 | 25.61 | 34.75 |
| Total Expenditure | 27.11 | 33.67 | 29.39 | 29.76 | 23.97 | 33.46 |
| PBIDT | 1.64 | 1.43 | 1.58 | 1.89 | 1.64 | 1.29 |
| Interest | 0.83 | 0.86 | 0.66 | 0.67 | 0.71 | 0.79 |
| PBDT | 0.80 | 0.56 | 0.92 | 1.22 | 0.93 | 0.50 |
| Depreciation | 0.19 | 0.20 | 0.19 | 0.26 | 0.20 | 0.20 |
| Tax | 0.16 | 0.10 | 0.23 | 0.26 | 0.20 | 0.08 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.01 | -0.01 | 0.09 | -0.06 | -0.06 | -0.05 |
| Reported Profit After Tax | 0.46 | 0.28 | 0.42 | 0.76 | 0.58 | 0.27 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.46 | 0.28 | 0.42 | 0.76 | 0.58 | 0.27 |
| EPS (Unit Curr.) | 0.59 | 0.36 | 0.51 | 0.97 | 0.74 | 0.35 |
| EPS (Adj) (Unit Curr.) | 0.59 | 0.36 | 0.51 | 0.97 | 0.74 | 0.35 |
| Calculated EPS (Unit Curr.) | 0.59 | 0.36 | 0.53 | 0.97 | 0.74 | 0.35 |
| Calculated EPS (Adj) (Unit Curr.) | 0.59 | 0.36 | 0.53 | 0.97 | 0.74 | 0.35 |
| Calculated EPS (Ann.) (Unit Curr.) | 2.36 | 1.44 | 2.13 | 3.87 | 2.96 | 1.39 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 2.36 | 1.44 | 2.13 | 3.87 | 2.96 | 1.39 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 5.71 | 4.08 | 5.30 | 6.15 | 6.40 | 3.74 |
| PBDTM(%) | 2.78 | 1.60 | 3.08 | 3.97 | 3.63 | 1.45 |
| PATM(%) | 1.60 | 0.80 | 1.41 | 2.47 | 2.26 | 0.78 |